83°F
weather icon Clear

FDA OKs 9 generic versions of nerve pain drug Lyrica

TRENTON, N.J. — The U.S. Food and Drug Administration has approved the first generic copies of a popular, pricey pill for nerve pain.

The agency on Monday said it approved nine generic versions of Pfizer Inc.’s Lyrica. It is also used for seizures and fibromyalgia, a condition that causes chronic, widespread pain.

Lyrica, approved in 2004, is Pfizer’s second bestseller, with sales last year of $4.6 billion. The heavily advertised drug costs about $460 to $720 per month without insurance, depending on the pharmacy. Prices can vary widely.

Prices for generic versions range from about $140 to $370 per month, according to the drug price comparison site GoodRx.

Common side effects include dizziness, blurred vision and sleepiness. Serious side effects include allergic reactions and life-threatening breathing problems.

MOST READ
Don't miss the big stories. Like us on Facebook.
THE LATEST
Study confirms suspicions about kids, germs

Autumn marks the start of respiratory virus season, when colds, flu and other bugs start circulating — especially among the very young.

When it comes to nutrition, more is not always better

Many of the nutrients we need for optimal health are only necessary in tiny amounts. If we continuously exceed those amounts, there may be consequences.

How to stay mentally sharp as you age

While our genes play a key role in determining our cognitive aging, our general health also plays a big factor.

Who pays for a skilled nursing stay, Medicare or you?

A stay in the hospital does not always mean you are an inpatient and that you qualify for skilled nursing facility care through Medicare Part A.

Who benefits from the MAHA anti-science push?

Powerful anti-vaccine advocates and people selling potentially harmful goods such as raw milk are profiting from the push to write anti-science policies into law across the U.S.

MORE STORIES